F17464 in Acute Schizophrenia Trial

NCT02151656 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: F17464
DRUG: Placebo

Sponsor

Pierre Fabre Medicament